No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study

[1]  R. Carr,et al.  A new perspective on NAFLD: focusing on lipid droplets. , 2021, Journal of hepatology.

[2]  Avash Das,et al.  TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease , 2021, Hepatology communications.

[3]  U. Huber-Schönauer,et al.  A sex-specific propensity-adjusted analysis of colonic adenoma detection rates in a screening cohort , 2021, Scientific Reports.

[4]  Balcar Lorenz,et al.  PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center , 2021, Zeitschrift für Gastroenterologie.

[5]  J. Danesh,et al.  SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. , 2021, European heart journal.

[6]  U. Huber-Schönauer,et al.  Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease , 2020, PloS one.

[7]  A. Schürmann,et al.  Genetic and epigenetic factors determining NAFLD risk , 2020, Molecular metabolism.

[8]  V. Wong,et al.  A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.

[9]  Donghee Kim,et al.  PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States , 2020, Journal of gastroenterology and hepatology.

[10]  F. Lammert,et al.  Towards genetic prediction of non-alcoholic fatty liver disease trajectories: PNPLA3 and beyond. , 2020, Gastroenterology.

[11]  C. Ruhl,et al.  Patatin‐Like Phospholipase Domain‐Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population , 2020, Hepatology.

[12]  Jonathan C. Cohen,et al.  Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis , 2019, Proceedings of the National Academy of Sciences.

[13]  M. Friedrich-Rust,et al.  Patatin‐like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events , 2018, Hepatology communications.

[14]  M. Rietschel,et al.  Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis , 2018, Gut.

[15]  Raquel S. Sevilla,et al.  Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.

[16]  A. Isaacs,et al.  PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease. , 2017, Gastroenterology.

[17]  Dermot F. Reilly,et al.  The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. , 2016, Gastroenterology.

[18]  S. Sookoian,et al.  The dual and opposite role of the TM6SF2‐rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta‐analysis , 2015, Hepatology.

[19]  E. Speliotes,et al.  TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? , 2015, Gastroenterology.

[20]  J. Borén,et al.  Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease , 2015, Hepatology.

[21]  F. Kronenberg,et al.  Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort , 2014, BMC Medical Genetics.

[22]  K. Clément,et al.  TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.

[23]  He Zhang,et al.  Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk , 2014, Nature Genetics.

[24]  M. Ridderstråle,et al.  Erratum to: The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels , 2014, Genes & Nutrition.

[25]  T. Hansen,et al.  The PNPLA3 rs738409 G-Allele Associates with Reduced Fasting Serum Triglyceride and Serum Cholesterol in Danes with Impaired Glucose Regulation , 2012, PloS one.

[26]  Udo Hoffmann,et al.  Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits , 2011, PLoS genetics.

[27]  E. Bugianesi,et al.  Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease , 2010, Hepatology.

[28]  F. Schick,et al.  Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene , 2009, Diabetes.

[29]  Tom R. Gaunt,et al.  American Journal of Epidemiology Practice of Epidemiology Hardy-weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2022 .